 zolgensma price strategi like
benchmark gene therapi drug
electr power util power/util macro trend tracker
internet digit media takeaway favorit name
strh annual idm confer
internet digit media internet- pick volatil take toll
idm group remain construct
midstream oil ga midstream thought earn
 opioid tracker belbuca share xtampza
digit entertain market strh idm
confer last week moder session cisn
well non-cov public tlra
privat attend across mobil game session
particularli notabl uniti skillz scope funplu other
cover compani ea crto host meet
investor came away comfort unchang
buy rate cisn lt thesi intact valuat near low
next leg tie new product slightli posit
hold-rat given recent sell-off/valu prospect
transact valuat remain constant calcul suggest
sale uk oper would accret
inc buy climb
ladder highlight travel cfo recent
travel cfo matthew foulston presid meal
solut triona schmelter head ir pi aquino visit
investor highlight meet includ updat
snack nut busi expect pivot top line
growth continu believ share overreact
weak opinion less relev result
expect benefit favor yoy comparison lap
sku reduct program price new innov believ
compani exceed street estim come
forward book volum price larg travel agenc
sourc came overal posit
departur though alway see out/
under-perform market industry-wid rest
observ reserv book y/i
global suppli price book reserv
compani reluct discuss
clearli observ strength reserv book
well global new suppli price book
internet digit media walk away
annual idm conf last week increment posit health
coverag univers macro/trad environ
remain major topic challeng fluid industri
commentari public privat particip
compani show strong posit momentum within group
especi among smid remain rel insul
favorit name come event includ angi
wix see summari link
full note youssef squali nave khan
inc buy climb
ladder highlight travel cfo recent
travel cfo matthew foulston presid meal
solut triona schmelter head ir pi aquino visit
investor highlight meet includ updat
snack nut busi expect pivot top line
growth continu believ share overreact
weak opinion less relev result
expect benefit favor yoy comparison lap
sku reduct program price new innov believ
compani exceed street estim come
forward book volum price larg travel agenc
sourc came overal posit
departur though alway see out/
under-perform market industry-wid rest
observ reserv book y/i
global suppli price book reserv
compani reluct discuss
clearli observ strength reserv book
well global new suppli price book
consum stapl last week cocoa price increas
higher cocoa price could neg impact
compani univers
electr power util
transact valuat remain constant calcul suggest
sale uk oper would accret
electr power util report includ analysi
key macro factor impact power/util sector includ
forward price spark spread dark spread gas/coal spread
page
trend domest electr consumpt growth nation
midstream oil ga us earn feel like forev
ago inject immedi multi-day la vega confer
tail end season improv hydrat
new antipathi toward electron danc music thought
worth quick recap gener estim revis
roserock hard place despit take privat headlin
see prefer layer squeez short interest
semg share continu under-perform broader midstream
absolut leverag level put c-corp unenvi posit
estim come broadli post neg
revis us ga place us lower end reiter
guidanc see share rang bound near term
debat take privat abil de-lev
push sentiment back forth revis estim
reduc pt ebitda rate
climb precipic summit far expect unit
remain subdu action address balanc sheet
come fruition view smlp like transact divestitur
year ahead doubl capital-expenditure purchas oblig
howev time remain difficult predict larg
unchang estim lower price target
ebitda discount similarli situat
peer rate unit hold tristan richardson
-flurri benefit aa share trade
lever prior strong beat revers think
attribut high correl broader midstream
think resili result aa great ski season help along
continu execut provid posit support
share near term upsid catalyst exist
increment re-contract estim assum
gradual recoveri new contract announc date
remain larg unchang follow quarter
bump tie mostli varianc rate share
page
incyt corpor buy jakafi approv
acut gvhd launch readi three gvhd dataset
line phase iib data hidraden suppurativa hs
deciphera phase gist data believ
top-line hit primari endpoint probabl
possibl drive stock neg data
push stock global blood full phase
data present eha presidenti symposium
june view posit read-through
may june focu read-
thru strh biotech peter lawson
 believ five-year outcome-bas
payment model gene therapi discuss avexi
bluebird signal converg payment model one-tim
gene therapi treatment eu cost
save compar variou benchmark convent chronic
treatment like win payer support
becom benchmark price set futur gene therapi
product rare diseas hemophilia hemophilia
 opinion edward nash
inflarx ifrx buy phase iib studi
hidraden suppurativa immin top-lin data
phase iib studi hs expect believ
investor expect hiscr respons rate higher
effect dose phase iib shine studi clinic
studi current on-going anca-associ vascul
aav compani commenc proof-of-concept studi
pyoderma gangraenosum pg due cours remain
optimist ifrx given encourag result phase
iia studi hs reaffirm buy rate edward
 buy rate
like safer opioid theme believ bdsi belbuca
coll xtampza er continu benefit physician
payer support time opioid use declin overal
help investor assess perform outlook
product track weekli volum trend use iqvia data
week end belbuca gain share xtampza
er share declin last week high market eros
stabl share bdsi symproic oic market declin
spike last week gregg gilbert gregori fraser
delay hous fail pass measur tobey sommer
page
internet digit media walk away
annual idm conf last week increment posit health
coverag univers macro/trad environ
remain major topic challeng fluid industri
commentari public privat particip
compani show strong posit momentum within group
especi among smid remain rel insul
favorit name come event includ angi
wix see summari link
full note youssef squali nave khan
digit entertain market strh idm
confer last week moder session cisn
well non-cov public tlra
privat attend across mobil game session
particularli notabl uniti skillz scope funplu other
cover compani ea crto host meet
investor came away comfort unchang
buy rate cisn lt thesi intact valuat near low
next leg tie new product slightli posit
hold-rat given recent sell-off/valu prospect
conf mtg latest traffic data analysi believ carguru
focus execut goal drive aarsd growth
increas connect volum add-on product
tweak unit price deliv superior user experi
dealer roi vs player compani relianc
long-tail keyword signific portion paid
organ traffic result rel small impact
headwind advers seo chang view continu
view aarsd upsid meaning top line growth
opportun see room materi improv margin
internet digit media recent pick-up volatil
idm group one worst week
vs yet given compani
minim exposur china secular growth trend
remain virtual intact base key takeaway
convers dozen public privat compani last
week remain posit bias valuat remain attract
ev/ntm ebitda trade well within histor
rang youssef squali nave khan
softwar interest new data point buy
 serv entir fortun privat compani fundrais
relev coupa buy hold
pluralsight ps buy competit wise privat hcm co
thought idm believ wix path
deliv sustain strong top line growth n/m term driven
page
double-digit growth sub well arpu
benefit ascend higher packaging/pr greater
agenc adoption/usag feature-bas price corvid higher
anticip traction new cs initi broader
rollout/adopt payment repres potenti upsid
est nave khan
page
june navig consult inc nci ndr chairwoman/ceo cfo director financ ir boston
june strh meet nyu intern hospit industri invest confer new york
june strh host meet expo- lo angel
june group dinner midatlant
page
june estimate conf call smith travel research stri
june jennif demba michael young bank atlanta
june jennif demba michael young bank new york
june youssef squali nave khan internet/digit media denver
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
